Navigation Links
Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma

LONDON, July 11, 2013 /PRNewswire/ --

On Wednesday, July 10, 2013, shares in biotechnology companies ended mostly higher even as the broader market ended on a mixed note. The major movers in the industry included Amgen Inc. (NASDAQ: AMGN), PDL BioPharma Inc. (NASDAQ: PDLI), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), and BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX). All these companies are tracked by Free technical research reports on AMGN, PDLI, QCOR, and BCRX can be accessed by signing up at:  

Shares in Amgen Inc. rose sharply on Wednesday, extending their gains for the week. The company's shares oscillated between $98.02 and $102.33 before finishing the day 3.79% higher at $102.26. A total of 4.18 million shares were traded which is above the daily average volume of 3.55 million. The company's shares have gained 4.53% so far this week, compared to a gain of 1.27% in the S&P 500. However, in the last three months, the stock has fallen by 5.72%. Download free report on AMGN upon registration at:

PDL BioPharma Inc.'s stock edged higher on Wednesday, extending its gains for the week. The company's shares oscillated between $8.06 and $8.15 before closing the session 1.24% higher at $8.15. A total of 1.71 million shares were traded which is below the daily average volume of 1.95 million. PDL BioPharma's shares have gained 3.16% so far this week, and 7.24% in the past three months, thus outperforming the S&P 500. PDLI technical report can be accessed for free by signing up at:

Shares in Questcor Pharmaceuticals Inc. edged lower on Wednesday, reversing some of their gains for the week. The company's shares ended the day 1.36% lower at $47.20 after oscillating between $47.04 and $48.57. A total of 1.87 million shares were traded which is below the daily average volume of 2.02 million. Despite Wednesday's pullback, the company's shares have gained 1.20% in the last three days and 63.95% in the last three months. A free report on QCOR can be accessed by registering at:

BioCryst Pharmaceuticals Inc.'s stock ended slightly higher on Wednesday, finishing at $1.63, up 0.62% from its previous closing price. The company's shares oscillated between $1.61 and $1.65. A total of 330,626 shares were traded which is less than its daily average volume of 818,150. The company's shares have fallen by 6.32% in the last three months. Register with AAA Research Reports and download research on BCRX for free at:



  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at
  5. For any urgent concerns or inquiries, please contact us at
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to for consideration.


Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.


Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.


Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Todays Technical View: Elan Corp., Amarin, Seattle Genetics, and Cubist Pharma
2. Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review
3. BC Technical Acquires MEDX
4. Call for Papers for Pittcon 2014 Technical Program
5. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
6. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
7. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
8. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
9. Technical Analysis on GNC Holdings and Walgreen: Drug Store Stocks Set to Provide Good Returns
10. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
11. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Titles Until the End of December at Chemical Publishing Company
Post Your Comments:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):